Cervical cancer screening overuse and underuse: patient and physician factors
- PMID: 23844709
Cervical cancer screening overuse and underuse: patient and physician factors
Abstract
Objectives: Despite recommendations for triennial cervical cancer screening for low-risk women 30 years and older, annual screening remains common. We studied how often women receiving care from an academically affiliated medical group were screened, and patient and provider factors associated with overuse and underuse. We also explored the impact of changing measurement intervals on computed screening frequency.
Design: The study included women 30 years and older continuously enrolled over a 3-year period and excluded women with history of abnormal screening and conditions of high risk for cervical cancer.
Methods: Administrative and laboratory data were merged to link Papanicolaou (pap) test results with patient and ordering provider characteristics. We used logistic regression to analyze multivariate models for overuse and underuse, and modified measurement intervals to test sensitivity to early and late pap smears.
Results: The 8018 women had a mean age of 48years and 95% had an ambulatory physician visit during the observation period. Thirty-four percent of women received guideline-based screening, 45% had overuse, and 21% had underuse. Factors independently associated with overuse included younger age, more medical visits, contraceptive management visits, and gynecology provider specialty. Underuse was associated with older age, fewer medical visits, and increased comorbidity.Overuse was 47% if unsatisfactory paps were not considered and was reduced to 35% if the observation interval was reduced from 36 to 30 months.
Conclusions: Overuse and underuse of cervical cancer screening are common and clinician and patient factors are identifiable to target quality improvement interventions. Modifying the measurement interval may improve the measure.
Similar articles
-
Physician recommendation for papanicolaou testing among U.S. women, 2000.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1143-8. doi: 10.1158/1055-9965.EPI-04-0559. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894664
-
Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.Am J Manag Care. 2010 Jun 1;16(6):e137-44. Am J Manag Care. 2010. PMID: 20536271
-
Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.Ann Intern Med. 2009 Nov 3;151(9):602-11. doi: 10.7326/0003-4819-151-9-200911030-00005. Ann Intern Med. 2009. PMID: 19884621
-
The state of overuse measurement: a critical review.Med Care Res Rev. 2013 Oct;70(5):473-96. doi: 10.1177/1077558713492202. Epub 2013 Jun 26. Med Care Res Rev. 2013. PMID: 23804290 Review.
-
Levers for addressing medical underuse and overuse: achieving high-value health care.Lancet. 2017 Jul 8;390(10090):191-202. doi: 10.1016/S0140-6736(16)32586-7. Epub 2017 Jan 9. Lancet. 2017. PMID: 28077228 Review.
Cited by
-
Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.Front Public Health. 2024 Apr 22;12:1321253. doi: 10.3389/fpubh.2024.1321253. eCollection 2024. Front Public Health. 2024. PMID: 38711762 Free PMC article.
-
Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.Elife. 2023 Sep 1;12:e85682. doi: 10.7554/eLife.85682. Elife. 2023. PMID: 37656169 Free PMC article.
-
Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.JAMA Netw Open. 2021 Apr 1;4(4):e218373. doi: 10.1001/jamanetworkopen.2021.8373. JAMA Netw Open. 2021. PMID: 33914050 Free PMC article.
-
Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.J Low Genit Tract Dis. 2019 Oct;23(4):253-258. doi: 10.1097/LGT.0000000000000484. J Low Genit Tract Dis. 2019. PMID: 31592972 Free PMC article.
-
Shared Decision-Making and Women's Adherence to Breast and Cervical Cancer Screenings.Int J Environ Res Public Health. 2018 Jul 17;15(7):1509. doi: 10.3390/ijerph15071509. Int J Environ Res Public Health. 2018. PMID: 30018244 Free PMC article.